Jubiglim M 4 Tablet

Jubiglim M 4 Tablet contains Glimepiride 4 mg + Metformin Hydrochloride (sustained/extended release) (strength unknown). Prescription required.

Type 2 diabetes mellitus (adult) to improve blood sugar control along with diet and exercise

Glimepiride (a sulfonylurea) increases insulin release from the pancreas and helps lower blood glucose. Metformin reduces glucose production in the liver and improves insulin sensitivity, lowering insulin resistance.

Oral tablet; take exactly as prescribed. Usually taken once daily with the first main meal (or as advised). Swallow whole; do not crush/chew if it is SR/ER. Monitor blood glucose regularly.

Hypoglycaemia (low blood sugar), nausea, vomiting, diarrhoea, abdominal discomfort, metallic taste, headache, dizziness, weight gain

Risk of hypoglycaemia (higher with missed meals, excess exercise, alcohol, elderly, kidney/liver impairment); carry sugar/glucose. Metformin may rarely cause lactic acidosis—seek urgent care for rapid breathing, severe weakness, abdominal pain, unusual sleepiness. Use with caution/adjust dose in kidney impairment; avoid in severe renal disease. Hold metformin before/after iodinated contrast studies or major surgery as advised by doctor. Monitor vitamin B12 with long-term use. Not for type 1 diabetes or diabetic ketoacidosis.

Alcohol (increases risk of hypoglycaemia and lactic acidosis), iodinated contrast media, insulin/other antidiabetics (additive hypoglycaemia), beta-blockers (mask hypoglycaemia symptoms), ACE inhibitors (may enhance glucose-lowering), corticosteroids/thiazide diuretics (raise glucose), fluoroquinolones (glucose disturbances), cimetidine and other drugs affecting renal clearance (increase metformin levels)

Store below 25°C in a dry place, protected from light and moisture. Keep in original blister pack. Keep out of reach of children.

Amaryl M 4 Tablet, Glimy M 4 Tablet, Glimstar M 4 Tablet, Glycomet-GP 4 Tablet, Zoryl-M 4 Tablet